Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable ...

The European Society for Medical Oncology (ESMO) and ASCO are publishing a new edition of the ESMO/ASCO Global Curriculum ... multiple changes and innovations have been incorporated in the GC 2023, ...

This 2023 Dodge Challenger R/T Scat Pack Widebody Mopar ‘23 Special Edition features a Pitch Black exterior with matte black graphics and Mopar Blue tracer stripes. It originally retailed for $ ...

Read our new eBook for simple strategies on how to incorporate new trends and AI tools for superior customer experiences Our eBook Next-Gen Cloud Contact Centers For Dummies® has simple strategies and ...

Windows 11 For Dummies, 2nd Edition brings you up to speed on the latest version of Windows, so you can make your PC operate the way you need it to with no guesswork. This straightforward and ...

Since first launching in March 2023, the spooky-yet-wholesome fishing ... A physical collector's edition filled tons of goodies releases later this year. Dredge Complete Collector's Edition ...

PDS Biotechnology Corporation isn’t one of the ... And welcome to PDS Biotech’s call to discuss the company’s Year-End 2023 Financial Results and Clinical Strategy Update Conference Call.

PDS Biotechnology (NASDAQ:PDSB) just reported results for the fourth quarter of 2023. PDS Biotechnology reported earnings per share of -35 cents. This was above the analyst estimate for EPS of -44 ...

Potentially dilutive common stock equivalents (stock options, restricted stock units and warrants) were not included in the non-GAAP adjusted diluted net loss as these shares would be considered ...

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology ... for the fourth quarter and fiscal year ended December 31, 2023. “2023 was a year of significant accomplishment and ...

Chicago, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The report "The Global Biotechnology Industry Outlook 2024", despite the economic uncertainties and post-COVID slump in recent times, biotech companies ...